Literature DB >> 8251595

The macrophage and HIV-1.

W Z Ho1, R Cherukuri, S D Douglas.   

Abstract

As described above, monocytes/macrophages from such diverse areas as the CNS, lungs, peripheral blood, cord blood, and liver are susceptible to infection by HIV-1 and may serve as reservoirs for transmitting the virus throughout the body. In contrast to lymphocytes, the chronic and low-level mode of infection that HIV-1 takes on within monocytes/macrophages allows these cells to contribute to persistent viral infection. Infection of these cells by HIV-1 can alter a variety of their immunological functions such as cytokine production, chemotaxis, accessory cell function, and microbicidal activity. Furthermore, macrophages and macrophage-related microglial cells in the brain and CSF are thought to play a critical role in the pathogenesis of CNS disease. Infection with HIV-1 in monocytes/macrophages is regulated in an autocrine manner by a panel of cytokines and other soluble factors. Most HIV-1 isolates exhibit specific tropism for monocytes/macrophages, lymphocytes, or, in some cases, both cell types; this phenomenon of tropism may be linked to structural variabilities between different isolates. While in vitro studies clearly demonstrate that the replicating cycle of HIV-1 in monocytes/macrophages differs from its replicating cycle in lymphocytes, elucidation of the role of monocyte/macrophages in mediating the severe immunosuppression characteristic of AIDS is far more from complete, and further investigation into the role of monocytes/macrophages in the immunopathogenesis of HIV-1 infection is necessary to design therapeutic approaches to control viral infection and disease progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8251595

Source DB:  PubMed          Journal:  Immunol Ser        ISSN: 0092-6019


  13 in total

1.  Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.

Authors:  J M Jacqué; B Fernández; F Arenzana-Seisdedos; D Thomas; F Baleux; J L Virelizier; F Bachelerie
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

2.  Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation.

Authors:  C DeLuca; A Roulston; A Koromilas; M A Wainberg; J Hiscott
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  The HIV-1 passage from cytoplasm to nucleus: the process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration.

Authors:  Kallesh Danappa Jayappa; Zhujun Ao; Xiaojian Yao
Journal:  Int J Biochem Mol Biol       Date:  2012-02-25

4.  Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.

Authors:  L Dubrovsky; P Ulrich; G J Nuovo; K R Manogue; A Cerami; M Bukrinsky
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

5.  Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT(1A) receptors.

Authors:  B Manéglier; G J Guillemin; P Clayette; C Rogez-Kreuz; B J Brew; D Dormont; C Advenier; P Therond; O Spreux-Varoquaux
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

Review 6.  Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors.

Authors:  A Roulston; R Lin; P Beauparlant; M A Wainberg; J Hiscott
Journal:  Microbiol Rev       Date:  1995-09

7.  The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes.

Authors:  Barbara Renga; Daniela Francisci; Claudio D'Amore; Elisabetta Schiaroli; Andrea Mencarelli; Sabrina Cipriani; Franco Baldelli; Stefano Fiorucci
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

Review 8.  Immunomodulatory effects mediated by serotonin.

Authors:  Rodrigo Arreola; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Marco Antonio Velasco-Velázquez; María Eugenia Garcés-Alvarez; Gabriela Hurtado-Alvarado; Saray Quintero-Fabian; Lenin Pavón
Journal:  J Immunol Res       Date:  2015-04-19       Impact factor: 4.818

9.  HIV-1 activates macrophages independent of Toll-like receptors.

Authors:  Joseph N Brown; James J Kohler; Carter R Coberley; John W Sleasman; Maureen M Goodenow
Journal:  PLoS One       Date:  2008-12-02       Impact factor: 3.240

10.  Materno-fetal transmission of human immune deficiency virus.

Authors:  A Schäfer
Journal:  Infect Dis Obstet Gynecol       Date:  1997
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.